Status:
COMPLETED
Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia
Lead Sponsor:
Novartis Slovakia, s.r.o.
Collaborating Sponsors:
Medirex Group Academy
Slovak Technical University
Conditions:
Diabetic Retinopathy
Diabetic Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to find out prevalence and individual stages of Diabetic Retinopathy in patients with type 1 and type 2 DM verified based on complex ophthalmologic measurements in Slovak Repub...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Signed informed consent for epidemiological research
- Signed informed consent for genetic research
- Patients with DM - type I and II regardless of the DM duration
- All DM patients must be included regardless of presence of eye complications in patient´s anamnesis or during the examination by the diabetologist Subgroups analysis
- Patients with DM - type I and II and DM duration ≥ 20 years
- Patients with DM - type I and II and DM duration \< 5 years and DR in history
Exclusion
- Age at the time of inclusion into the \<18 years
- Gestational DM or secondary-induced diabetes
- Diabetic ketoacidosis or hyperosmolar coma
- Alcohol abuse or acute alcohol intoxication
Key Trial Info
Start Date :
February 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
4011 Patients enrolled
Trial Details
Trial ID
NCT02232503
Start Date
February 1 2015
End Date
November 1 2015
Last Update
September 22 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.